พอดคาสท์ Clinicaltrials ชั้นนำ (2024)

1
Developing Recurring Revenue Health and Wellness Products and Services to Optimize Patient Experience and Build Loyalty with Matt Cronin House of Kaizen TRANSCRIPT

15h ago

—

Matt Cronin, Founding Partner of House of Kaizen, discusses how patients' changing healthcare expectations are shaped by their experiences with products and services such as Netflix and Amazon Prime. Consumers now expect a longer-term relationship and personalized experiences with their healthcare providers. House of Kaizen emphasizes the importanc…

1
Developing Recurring Revenue Health and Wellness Products and Services to Optimize Patient Experience and Build Loyalty with Matt Cronin House of Kaizen 19:59

15h ago19:59

19:59

Matt Cronin, Founding Partner of House of Kaizen, discusses how patients' changing healthcare expectations are shaped by their experiences with products and services such as Netflix and Amazon Prime. Consumers now expect a longer-term relationship and personalized experiences with their healthcare providers. House of Kaizen emphasizes the importanc…

1
Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni Kura Oncology TRANSCRIPT

1d ago

—

Dr. Mollie Leoni, Executive Vice President for Clinical Development of Kura Oncology, discusses the company's ziftomenib program, a menin inhibitor for acute myeloid leukemia (AML). The company initially allowed all AML patients to participate in the clinical study, but later found that specific subtypes, such as those with NPM1 mutation or KMT2A r…

1
Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni Kura Oncology 18:16

1d ago18:16

18:16

Dr. Mollie Leoni, Executive Vice President for Clinical Development of Kura Oncology, discusses the company's ziftomenib program, a menin inhibitor for acute myeloid leukemia (AML). The company initially allowed all AML patients to participate in the clinical study, but later found that specific subtypes, such as those with NPM1 mutation or KMT2A r…

1
New Landscape for Controlling Obesity and Lowering Incidence of Related Diseases with Dr. Steffen-Sebastian Bolz Aphaia Pharma TRANSCRIPT

2d ago

—

Dr. Steffen-Sebastian Bolz, Chief Scientific Officer of Swiss-based Aphaia Pharma, shines a light on the excitement around weight loss drugs due to the discovery that GLP-1 agonists and points out the shift in the perception of obesity as a root cause of various health issues. Aphaia Pharma's approach involves stimulating hormone production in the …

1
New Landscape for Controlling Obesity and Lowering Incidence of Related Diseases with Dr. Steffen-Sebastian Bolz Aphaia Pharma 21:01

2d ago21:01

21:01

Dr. Steffen-Sebastian Bolz, Chief Scientific Officer of Swiss-based Aphaia Pharma, shines a light on the excitement around weight loss drugs due to the discovery that GLP-1 agonists and points out the shift in the perception of obesity as a root cause of various health issues. Aphaia Pharma's approach involves stimulating hormone production in the …

1
Episode 474 - Amy Gietzen 11:51

3d ago11:51

11:51

Amy Gietzen, a patient diagnosed with systemic scleroderma, shares her journey and experiences living with the disease. She discusses her initial symptoms, the shock of the diagnosis, and the lack of information and resources available at the time. Despite facing numerous challenges, including pulmonary fibrosis and pulmonary arterial hypertension,…

1
Journal Editorial - Challenge–skill balance in cardiac surgery: an attempt to explain sex-related differences in coronary surgery 10:06

3d ago10:06

10:06

With Torsten Doenst & Philine Fleckenstein, Jena University Hospital, Friedrich Schiller University of Jena - Germany. Link to paper Link to editorialโดย European Society of Cardiology

1
Jun 21 2024 This Week in Cardiology 27:25

5d ago27:25

27:25

MRAs in HF with renal dysfunction, coronary autoregulation, the hubris of US doctors, NSTEMI in older patients, survival after STEMI, and new leaders at JACC are discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feed…

1
Healthcare Outcomes When Hospitals Embrace Vertical Farming with Rick Vanzura Freight Farms and Dr. Amber Orman Advent Health TRANSCRIPT

6d ago

—

Rick Vanzura, CEO of Freight Farms, and Dr. Amber Orman, Chief Wellness Officer at Advent Health, discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities. Freight Farms uses modified shipping containers to grow crops, allowing for year-round production with minimal land and water usage. Advent Health recognized t…

1
Healthcare Outcomes When Hospitals Embrace Vertical Farming with Rick Vanzura Freight Farms and Dr. Amber Orman Advent Health 22:28

6d ago22:28

22:28

Rick Vanzura, CEO of Freight Farms, and Dr. Amber Orman, Chief Wellness Officer at Advent Health, discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities. Freight Farms uses modified shipping containers to grow crops, allowing for year-round production with minimal land and water usage. Advent Health recognized t…

1
Advancements in Gene Therapy for Rare Ocular Disease and Metabolic Disorders with Guang Qu NGGT Corporation TRANSCRIPT

7d ago

—

Guang Qu, Co-Founder of NGGT Corporation is focused on developing gene therapy products using dual functional vector strategies. Guang highlights the importance of distinguishing between recessive and dominant mutations in rare diseases and explains how their approach differs from other gene therapy approaches. The two leading indications caused by…

1
Advancements in Gene Therapy for Rare Ocular Disease and Metabolic Disorders with Guang Qu NGGT Corporation 21:45

7d ago21:45

21:45

Guang Qu, Co-Founder of NGGT Corporation is focused on developing gene therapy products using dual functional vector strategies. Guang highlights the importance of distinguishing between recessive and dominant mutations in rare diseases and explains how their approach differs from other gene therapy approaches. The two leading indications caused by…

1
Season 2 - Ep.18: Genetic testing in dilated cardiomyopathy - Gut microbiome and heart disease 22:07

6d ago22:07

22:07

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Genetic testing in dilated cardiomyopathy Gut microbiome and heart disease Mythbusters: Sitting is the new smoking Host: Rick Grob…

1
New Scaffold for Treating Severe Peripheral Artery Disease Below the Knee with Jennifer Jones-McMeans Abbott and Dr. Brian DeRubertis TRANSCRIPT

8d ago

—

Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbo…

1
New Scaffold for Treating Severe Peripheral Artery Disease Below the Knee with Jennifer Jones-McMeans Abbott and Dr. Brian DeRubertis 22:08

8d ago22:08

22:08

Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbo…

1
Developing Essential Tremor and Other CNS Therapies with Marcio Souza Praxis Precision Medicines TRANSCRIPT

9d ago

—

Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the challenges in treating central nervous system disorders and is focused on developing life-altering treatments for patients with essential tremor. Current treatments for epilepsy are often broad-based and not specific to the underlying cause of the disease. Praxis is using …

1
Developing Essential Tremor and Other CNS Therapies with Marcio Souza Praxis Precision Medicines 19:10

9d ago19:10

19:10

Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the challenges in treating central nervous system disorders and is focused on developing life-altering treatments for patients with essential tremor. Current treatments for epilepsy are often broad-based and not specific to the underlying cause of the disease. Praxis is using …

1
Episode 473 - Alvin Rocha MSN RN CPN PHN 10:18

10d ago10:18

10:18

Alvin Rocha is a nurse care manager and pulmonary hypertension coordinator at Children's Hospital Los Angeles. He manages PH patients from birth to early adulthood. His main goal is to prepare these patients for the transition into the adult world. He is excited about the advancements in therapies and clinical trials and looks forward to attending …

1
Driving Interoperability and Ubiquitous Access to Healthcare Information with Dr. John Blair MedAllies TRANSCRIPT

10d ago

—

Dr. John Blair, CEO of MedAllies, was created to address the lack of communication and coordination between healthcare providers and the importance of interoperability in healthcare. While healthcare has become more complicated over the years, with advancements in technology and automation, the lack of reimbursement for coordination of care has con…

1
Driving Interoperability and Ubiquitous Access to Healthcare Information with Dr. John Blair MedAllies 21:15

10d ago21:15

21:15

Dr. John Blair, CEO of MedAllies, was created to address the lack of communication and coordination between healthcare providers and the importance of interoperability in healthcare. While healthcare has become more complicated over the years, with advancements in technology and automation, the lack of reimbursement for coordination of care has con…

1
Jun 14 2024 This Week in Cardiology 30:52

12d ago30:52

30:52

Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Listener …

1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics TRANSCRIPT

15d ago

—

Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…

1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics 19:11

15d ago19:11

19:11

Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…

1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC TRANSCRIPT

16d ago

—

Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …

1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC 19:27

16d ago19:27

19:27

Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …

1
Food Is Not Medicine but Maybe It's Healthcare 21:29

17d ago21:29

21:29

Bob Harrington and Mitch Elkind discuss "food is medicine" initiatives and the challenges associated with conducting clinical trials. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Health Care by Food Initiative https://healthcarexfood.org/ 2021 Di…

พอดคาสต์ที่ควรค่าแก่การฟัง

Clinicaltrials พอดคาสต์

พอดคาสต์ที่ควรค่าแก่การฟัง

คู่มืออ้างอิงด่วน